lung in Medical News

LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense

WASHINGTON, Aug. 6 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) said today that bids are now being requested for another $11.8 million of the $20 million lung cancer research project funded through the Department of Defense's Congressionally Directed Medical Research Program (CD...

Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations

RIDGEFIELD, Conn., Aug. 3 /PRNewswire/ -- Boehringer Ingelheim announced today at the International Association for the Study of Lung Cancer's 13th World Conference on Lung Cancer (WCLC), San Francisco, CA, the initiation of a Phase III clinical study of BIBW 2992 as first-line treatment...

Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapy

SAN FRANCISCO (August 1, 2009)Non-small cell lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer. Both cetuxima...

Fox Chase finds all-biologic regimen efficacious and well-tolerated in elderly lung cancer patients

SAN FRANCISCO (August 1, 2009)Previously untreated non-small cell lung cancer (NSCLC) patients over the age of 70 respond well to a combination of bevacizumab and erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of L...

Fox Chase researchers identify differences in treatments and outcomes of patients with second primary lung cancers versus those with one primary lung cancer

SAN FRANCISCO (August 1, 2009)Patients with second primary lung cancers (SPLC), when compared to those with one primary lung cancer (OPLC), are more likely to have localized disease at the time of diagnosis and are more likely to receive surgical treatment rather than radiation treatment. However,...

Advanced targeted therapies effective as first-line treatment for lung cancer

SAN FRANCISCO, August 1, 2009 The world's top lung cancer specialists, medical professionals and researchers are convening this week in San Francisco, CA for the 13th World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC). According...

Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc.

SAN FRANCISCO, July 31 /PRNewswire-USNewswire/ -- The Addario Lung Cancer Medical Institute (ALCMI) today announced the execution of a letter of intent (LOI) to collaborate with Response Genetics, Inc. (Nasdaq: RGDX ) on molecular diagnostic testing and banking of advanced-stage Lung...

AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer

WILMINGTON, Del., July 30 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) today announced the company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for an inves...

Viagra Trial for Sickle Cell Lung Problems Halted

Safety concern from side effects prompts action by U.S. government TUESDAY, July 28 (HealthDay News) -- The first clinical trial of a treatment for pulmonary hypertension in adults with sickle cell anemia has been stopped because of severe side effects in some participants. The tria...

Molecule plays early role in nonsmoking lung cancer

COLUMBUS, Ohio The cause of lung cancer in never-smokers is poorly understood, but a study led by investigators at the Ohio State University Comprehensive Cancer Center and at the National Cancer Institute has identified a molecule believed to play an early and important role in its development. ...

Radiation Plus Chemo a Good Option in Lung Cancer

Surgery alone not linked to improved survival in non-small-cell lung cancer study MONDAY, July 27 (HealthDay News) -- Radiotherapy plus chemotherapy, with or without surgery, works well for people with stage 3A non-small-cell lung cancer, a new study has found. Stage 3A is declared ...

Lilly to Unveil More Than 30 Studies at Premier Lung Cancer Meeting

INDIANAPOLIS, July 27 /PRNewswire-FirstCall/ -- Eli Lilly and Company continues to lead the way in advancing lung cancer treatment. On the heels of new FDA and European Commission approvals for ALIMTA((R)) (pemetrexed for injection) as a treatment for nonsquamous non-small cell lung can...

Surgery remans an option for advanced lung cancer

MAYWOOD, Il. In recent years, oncologists have debated whether patients with a certain type of advanced lung cancer would benefit from surgery. Now a major study published in the journal The Lancet has found that surgery after standard chemotherapy and radiation can be an option for patient...

Ovary Removal May Play a Role in Lung Cancer

Increased risk could stem from sudden drop in estrogen, experts say FRIDAY, July 24 (HealthDay News) -- Medically induced menopause, particularly when it involves removal of both ovaries, nearly doubles a younger woman's risk for developing lung cancer, a new Canadian study has found. ...

Lung Cancer Alliance Announces First 'Request For Bids' for Department of Defense Lung Cancer Research Program 'Concept Awards'

Established under the DOD Congressionally Directed Medical Research Program for Lung Cancer WASHINGTON, July 23 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) announced that the Department of Defense Congressionally Directed Medical Research Program (CDMRP) is al...

Ovary removal may increase lung cancer risk

This press release is available in French . Montreal, July 21, 2009 Women who have premature menopause because of medical interventions are at an increased risk of developing lung cancer, according to a new study published in the International Journal of Cancer . The startling link was ma...

Small Molecule Might Play Big Part in Lung Cancer

High levels of miR-21 were found in nonsmoking patients; could be target for treatment SATURDAY, July 18 (HealthDay News) -- Researchers have isolated a small molecule that might play a big part in a form of lung cancer that typically strikes people who have never smoked, opening up th...

New lung cancer staging system revealed

For the first time in more than 10 years, the universally accepted lung cancer staging system has been revised to more accurately reflect the prognosis for patients with non-small cell lung cancer (NSCLC). A new report in the July issue of CHEST , the peer-reviewed journal of the American Col...

Genetic Breakthrough Spells Hope for Lung Fibrosis Patients

Might help those with advanced disease buy time until transplant, study shows WEDNESDAY, July 8 (HealthDay News) -- Genes that can help doctors predict when patients with idiopathic pulmonary fibrosis are becoming seriously ill have been identified by U.S. researchers, who said the fin...

Cell Pathway May Be Key to Lung Cancer's Spread

Researchers express hope that finding will lead to treatments,, FRIDAY, July 3 (HealthDay News) -- U.S. researchers say they've found a major cellular flaw that may drive the rapid spread of relapsed lung cancer. When caught early, lung cancer can often be treated. But most cases a...

Lung Cancer Alliance Releases Updated 2009 Facts About Lung Cancer

Renews Call for National Strategy to Better Address the Disease WASHINGTON, June 30 /PRNewswire-USNewswire/ -- Today Lung Cancer Alliance (LCA) released its updated 2009 Facts About Lung Cancer illustrating again the devastating toll caused by lung cancer. LCA last released its Fact Shee...

Possible benefit from online genetic testing for lung cancer

PHILADELPHIA - As scientists continue to decode the human genome and the information becomes publicly available, private companies that offer online genetic testing are multiplying. Scientists at the National Institutes of Health were concerned that perhaps these tests posed a risk. They evalua...

Drug Found Ineffective Against Lung Disease

People with idiopathic pulmonary fibrosis gain no survival benefit, research finds,, MONDAY, June 29 (HealthDay News) -- Treatment with interferon gamma-1b (Ifn-g1b) does not improve survival in people with a fatal lung disease called idiopathic pulmonary fibrosis, according to a stud...

Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018

Emerging Agents from Pfizer, AstraZeneca, GlaxoSmithKline, Bayer/Onyx and Boehringer Ingelheim, and Increased Use of Existing Agents from Eli Lilly and Roche Will Drive Growth, According to a New Report from Decision Resources WALTHAM, Mass., June 29 /PRNewswire/ -- Decision Resources, one of...

Soy in the Diet May Protect Lung Function

Chronic lung disease rates lower in those who consume soy, researchers say FRIDAY, June 26 (HealthDay News) -- Consuming lots of soy foods such as tofu and soy milk may improve lung function and lower the chances of developing chronic obstructive pulmonary disease (COPD), new research ...

Lung Cancer Alliance Hails Signing of Tobacco Control Legislation Into Law; Urges Action on Lung Cancer

WASHINGTON, June 23 /PRNewswire-USNewswire/ -- Landmark legislation giving the Food and Drug Administration (FDA) the power to regulate tobacco products was signed into law at a White House ceremony today. (Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ) The federal ...

Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer

Epidermal Growth Factor Receptor Mutation Test May Be Key To Identifying Patient Response to Drug Therapies ALISO VIEJO, Calif., June 16 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT ), a premier anatomic pathology and molecular testing services resource for pathologists, oncologis...

Nicotine Receptors Could Be Lung Cancer Treatment Target

Compound inhibited receptors and led to cancer cell death in mouse study MONDAY, June 15 (HealthDay News) -- In a study of mice with lung cancer, a treatment that targeted nicotine receptors more than doubled the animals' survival time, Italian researchers say. Nicotine plays a dual...

New York State Department of Transportation and American Lung Association in New York Announce 'Commit to Cleaner Air' Week

Citizens Encouraged to Take Action by Pledging to Improve Downstate NY's Air Quality ALBANY, N.Y., June 15 /PRNewswire/ -- New York State Department of Transportation (NYSDOT) Acting Commissioner Stan Gee, in partnership with the American Lung Association in New York, today declared the week...

American Lung Association in Iowa Thanks Senators Harkin and Grassley for Votes to Pass Legislation Granting FDA Authority Over Tobacco Products

DES MOINES, Iowa, June 11 /PRNewswire-USNewswire/ -- The American Lung Association in Iowa is happy to report the U.S. Senate's 79 to 17 vote in favor of the Family Smoking Prevention and Tobacco Control Act (HR 1256) today. The American Lung in Association in Iowa applauds Senators Tom Har...

ASCO Research Foundation Grant Will Support Study of Peregrine's Bavituximab in Lung Cancer

- Career Development Award to Study Biology of Bavituximab and Chemotherapy in Lung Cancer Awarded to Dr. David Gerber of UT Southwestern Medical Center - - New Study Complements Ongoing Bavituximab Plus Carboplatin/Paclitaxel Phase II NSCLC Trial that has Shown Promising Preliminary Results ...

Defeating nicotine's double role in lung cancer

A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers. The results of the early phase animal model study were reported in the June 15 issue of the American Journal of Respiratory and Critical Care Medicine . Ch...

Protein may be strongest indicator of rare lung disease, study shows

CINCINNATIResearchers at the University of Cincinnati (UC) have discovered a protein in the lungs that can help in determining progression of the rare lung disease Idiopathic Pulmonary Fibrosis (IPF). Researchers say the proteinSerum surfactant protein Ais superior to other IPF predictors and c...

New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography

New Merck KGaA Study Reveals Wide Variations in Therapy Regimens, with Monotherapy Most Common in Elderly Patients and Triplets Most Prevalent in the US ORLANDO, Fla., June 1 /PRNewswire/ -- There are striking differences in treatment regimens for non-small cell lung cancer (NSCLC) patients, ...

Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs

AURORA, Colo. -- A study published in the June 2009 issue of the Journal of Thoracic Oncology determined several predictors of a positive lung cancer diagnosis after having an abnormal chest x-ray. Dr. Martin Carl Tammemagi of Brock University in Ontario and his team of US researchers examined t...

Vandetanib shows clinical benefit when combined with docetaxel for lung cancer

ORLANDO - When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cance...

Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer

WAYNE, N.J. and EMERYVILLE, Calif., June 1 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar(R) (sorafenib) tablets...

Drug Trials Show Modest Gains Against Lung Cancer

Alimta, Zactima extend survival but cure remains out of reach, studies show SATURDAY, May 30 (HealthDay News) -- Certain drugs offer incremental yet significant improvements in pushing back advanced lung cancer. That's the conclusion of studies presented Saturday at the annual meeti...

HRT Ups Death Risk for Women With Lung Cancer

Shortened survival points to estrogen's potential role in the disease, experts say SATURDAY, May 30 (HealthDay News) -- The current use of combined hormone replacement therapy (HRT) is associated with a higher risk of dying for women diagnosed with non-small cell lung cancer, a new stu...

Drug Combo Proves Powerful Against Lung Cancer

Study finds better outcome for advanced non-small cell malignancies SATURDAY, May 30 (HealthDay News) -- A two-drug combination treatment proved successful in safely slowing advanced non-small cell lung cancer in a recent clinical trial. In the study, a phase 3 trial involving 768 ...